Holen Sie sich die Stockscreener-App
0.945
1.72%
0.016
Schlusskurs vom Vortag:
$0.929
Offen:
$0.93
24-Stunden-Volumen:
2.89M
Relative Volume:
20.47
Marktkapitalisierung:
$3.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.64M
KGV:
-0.1365
EPS:
-6.9236
Netto-Cashflow:
$-10.11M
1W Leistung:
+1.12%
1M Leistung:
-46.61%
6M Leistung:
-61.11%
1J Leistung:
-54.13%
1-Tages-Spanne:
$0.893
$0.95
1-Wochen-Bereich:
$0.881
$0.99
52-Wochen-Spanne:
$0.881
$4.10
Gt Biopharma Inc Stock (GTBP) Company Profile
Firmenname
Gt Biopharma Inc
Sektor
Branche
Telefon
(800) 304-9888
Adresse
505 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie GTBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 0.2846 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
1.78 | 1.86B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.48 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.37 | 103.78M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.3441 | 797.28M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.15 | 0 | 0 | 0 | 0 | 0.00 |
Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | ROTH MKM | Buy |
| 2021-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-13 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-17 | Eingeleitet | ROTH Capital | Buy |
Gt Biopharma Inc Aktie (GTBP) Neueste Nachrichten
Can technical indicators confirm GT Biopharma Inc.’s reversalTrade Signal Summary & Free Real-Time Market Sentiment Alerts - Newser
Signal strength of GT Biopharma Inc. stock in tech scannersEarnings Recap Report & Advanced Swing Trade Entry Alerts - Newser
Is GT Biopharma Inc. stock poised for growthJuly 2025 Rallies & Technical Analysis for Trade Confirmation - Newser
Is GT Biopharma Inc. stock trending bullishQuarterly Performance Summary & High Win Rate Trade Tips - خودرو بانک
Can GT Biopharma Inc. ride the EV waveM&A Rumor & Free High Accuracy Swing Entry Alerts - خودرو بانک
What’s the analyst consensus on GT Biopharma Inc.Portfolio Gains Report & Fast Moving Stock Trade Plans - خودرو بانک
Can GT Biopharma Inc. hit a new high this month2025 Trade Ideas & Safe Entry Momentum Stock Tips - Newser
What technical models suggest about GT Biopharma Inc.’s comebackMarket Growth Report & Weekly Top Gainers Trade List - Newser
Quantitative breakdown of GT Biopharma Inc. recent moveMarket Sentiment Review & Weekly Consistent Profit Watchlists - Newser
Is GT Biopharma Inc. stock risky to hold nowQuarterly Earnings Summary & Weekly Hot Stock Watchlists - خودرو بانک
Reversal indicators forming on GT Biopharma Inc. stockMarket Volume Summary & AI Driven Stock Movement Reports - Newser
Published on: 2025-09-05 05:42:32 - Newser
Statistical indicators supporting GT Biopharma Inc.’s strengthWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - Newser
Smart tools for monitoring GT Biopharma Inc.’s price actionJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Is GT Biopharma Inc. meeting your algorithmic filter criteriaIPO Watch & AI Driven Stock Reports - Newser
Chart overlay techniques for tracking GT Biopharma Inc.Weekly Investment Report & Verified Swing Trading Watchlist - Newser
Candlestick signals on GT Biopharma Inc. stock today2025 Trading Volume Trends & Expert Approved Momentum Trade Ideas - Newser
Is it too late to sell GT Biopharma Inc.Recession Risk & Safe Entry Point Identification - Newser
GT Biopharma Reports Reduced Losses Amid Ongoing Challenges - TipRanks
Can machine learning forecast GT Biopharma Inc. recoveryQuarterly Investment Review & Capital Efficient Trade Techniques - Newser
Is GT Biopharma Inc. a candidate for recovery play2025 Growth vs Value & Risk Managed Investment Entry Signals - Newser
Is GT Biopharma Inc. in a long term uptrendWeekly Profit Recap & Target Return Focused Picks - خودرو بانک
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Clinical-Stage NK Cell Therapy: GT Biopharma Advancing Two Key Cancer Programs with 2025 Milestones - Stock Titan
How moving averages guide GT Biopharma Inc. tradingRecession Risk & Consistent Growth Stock Picks - Newser
How to interpret RSI for GT Biopharma Inc. stockWeekly Stock Recap & Weekly Return Optimization Alerts - Newser
Using data tools to time your GT Biopharma Inc. exit2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Real time scanner hits for GT Biopharma Inc. explainedMarket Movement Recap & Verified Technical Signals - Newser
Merger Talk: Can GT Biopharma Inc. ride the EV waveJuly 2025 Outlook & High Return Stock Watch Alerts - خودرو بانک
What MACD and RSI say about GT Biopharma Inc.July 2025 Final Week & Free Weekly Chart Analysis and Trade Guides - Newser
Will breakout in GT Biopharma Inc. lead to full recovery2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Market reaction to GT Biopharma Inc.’s recent newsDollar Strength & Safe Investment Capital Preservation Plans - Newser
What MACD and RSI say about GT Biopharma IncEarnings Performance Report & Real-Time Stock Entry Alerts - Newser
How to read the order book for GT Biopharma Inc.Market Growth Summary & Scalable Portfolio Growth Methods - Newser
GT Biopharma Inc. stock daily chart insightsBuy Signal & Low Drawdown Trading Strategies - Newser
Institutional scanner results for GT Biopharma Inc.Market Trend Summary & Free Weekly Watchlist of Top Performers - Newser
Finanzdaten der Gt Biopharma Inc-Aktie (GTBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):